BEONE MEDICINES LTD. (BEIGF) Net income 2016–2025
BEONE MEDICINES LTD. (BEIGF) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$286.9MFY2025 · since FY2016: -$119.2M → $286.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $286.9M | +144.5% |
| FY2024 | -$644.8M | +26.9% |
| FY2023 | -$881.7M | +56.0% |
| FY2022 | -$2.0B | -37.5% |
| FY2021 | -$1.5B | +10.3% |
| FY2020 | -$1.6B | -71.3% |
| FY2019 | -$948.6M | -40.8% |
| FY2018 | -$673.8M | -623.7% |
| FY2017 | -$93.1M | +21.9% |
| FY2016 | -$119.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BEIGF financial trends
BEIGF RevenueBEIGF Net marginBEIGF Gross profitBEIGF Gross marginBEIGF Operating incomeBEIGF Operating marginBEIGF Operating cash flowBEIGF Free cash flowBEIGF Capital expendituresBEIGF Return on equityBEIGF Stock buybacksBEIGF Dividends paidBEIGF Total assetsBEIGF Total liabilitiesBEIGF Shareholders’ equityBEIGF overview →